Treatment of transplant kidneys during machine perfusion
Open Access
- 24 September 2020
- journal article
- review article
- Published by Frontiers Media SA in Transplant International
- Vol. 34 (2), 224-232
- https://doi.org/10.1111/tri.13751
Abstract
The increasing use of donation after circulatory death (DCD) and extended criteria donor (ECD) organs has raised awareness of the need to improve the quality of kidneys for transplantation. Treating kidneys during the preservation interval could improve early and long‐term graft function and survival. Dynamic modes of preservation including hypothermic machine perfusion (HMP) and normothermic machine perfusion (NMP) may provide the functional platforms to treat these kidneys. Therapies in the field of regenerative medicine including cellular therapies and genetic modification and the application of biological agents targeting ischaemia reperfusion injury (IRI) and acute rejection are a growing area of research. This review reports on the application of cellular and gene manipulating therapies, nanoparticles, anti‐inflammatory agents, anti‐thrombolytic agents and monoclonal antibodies administered during HMP and NMP in experimental models. The review also reports on the clinical effectiveness of several biological agents administered during HMP. All of the experimental studies provide proof of principle that therapies can be successfully delivered during HMP and NMP. However, few have examined the effects after transplantation. Evidence for clinical application during HMP is sparse and only one study has demonstrated a beneficial effect on graft function. More investigation is needed to develop perfusion strategies and investigate the different experimental approaches.Keywords
Funding Information
- National Institute for Social Care and Health Research
This publication has 47 references indexed in Scilit:
- Normothermic machine perfusion of the kidney: better conditioning and repair?Transplant International, 2014
- Modifying the vessel walls in porcine kidneys during machine perfusionJournal of Surgical Research, 2014
- Renal Transplantation After Ex Vivo Normothermic Perfusion: The First Clinical StudyAmerican Journal of Transplantation, 2013
- Innate immunity activation involved in unprotected porcine auto-transplant kidneys preserved by naked caspase-3 siRNAJournal of Translational Medicine, 2013
- Naked caspase 3 small interfering RNA is effective in cold preservation but not in autotransplantation of porcine kidneysJournal of Surgical Research, 2012
- Pretransplant Kidney-Specific Treatment to Eliminate the Need for Systemic ImmunosuppressionTransplantation, 2010
- Genetic modification of somatic stem cellsEMBO Reports, 2008
- Gene therapy and solid-organ transplantationKidney International, 2002
- Use of anti-(tumour necrosis factor-α) antibody or 3-deaza-adenosine as additives to promote protection by University of Wisconsin solution in ischaemia/reperfusion injuryClinical Science, 2000
- Prostaglandin E1 Influences Pulsatile Preservation Characteristics and Early Graft Function in Expanded Criteria Donor KidneysJournal of Surgical Research, 1999